Related Experiment Video
Updated: Jun 28, 2025

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
Cyclocurcumin as Promising Bioactive Natural Compound: An Overview
Carla Gasbarri1, Guido Angelini1
1Department of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Via dei Vestini, 66100 Chieti, Italy.
Cyclocurcumin, a turmeric compound, exhibits unique reactivity and promising therapeutic potential for degenerative and cardiovascular diseases. However, its clinical use is limited by poor solubility and bioavailability.
Area of Science:
- Natural product chemistry
- Medicinal chemistry
Background:
- Curcumin and cyclocurcumin are natural compounds from turmeric with distinct reactivities.
- Cyclocurcumin possesses unique hydrophobic properties, including fluorescence and aggregation behavior.
Purpose of the Study:
- To investigate the chemical reactivity and biological potential of cyclocurcumin.
- To compare cyclocurcumin with curcumin, another bioactive compound from turmeric.
Main Methods:
- Chemical analysis of reactivity (tautomerism vs. isomerization).
- Characterization of physicochemical properties (hydrophobicity, fluorescence, aggregation).
- Molecular docking for predicting bioactivity (antioxidant, enzyme inhibition, antiviral).
Main Results:
- Cyclocurcumin undergoes trans-cis isomerization, unlike curcumin's tautomerism.
- Cyclocurcumin displays fluorescence, solvatochromism, and forms aggregates in water.
- Molecular docking suggests potential as an antioxidant, enzyme inhibitor, and antiviral agent, particularly for degenerative and cardiovascular diseases.
Conclusions:
- Cyclocurcumin is a bioactive compound with diverse therapeutic potential.
- Low solubility and bioavailability hinder cyclocurcumin's clinical applications.
- Further research is needed to overcome formulation challenges for cyclocurcumin.
More Related Videos
09:50Author Spotlight: Eco-friendly Photoluminescent Textile Authentication with Curcumin
Published on: December 22, 2023
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Inhibition of Cdk Activity
Positive Regulator Molecules
Cycloaddition Reactions: Overview
Drugs that Stabilize Microtubules
The Citric Acid Cycle: Overview
The citric...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...